{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:32:29Z","timestamp":1790397149175,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T00:00:00Z","timestamp":1752969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.prp.2025.156139","type":"journal-article","created":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T14:25:01Z","timestamp":1753021501000},"page":"156139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Clinicopathological features and prognostic insights of cutaneous versus non-cutaneous angiosarcoma: A retrospective single-center cohort study"],"prefix":"10.1016","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9573-7029","authenticated-orcid":false,"given":"Davide","family":"Voci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Grigorean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Neuenschwander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Lisy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo M.","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Kucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf P.","family":"Engelberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prp.2025.156139_bib1","first-page":"1","article-title":"Head and neck sarcoma: report of the Head and Neck Sarcoma Registry","volume":"14","author":"Wanebo","year":"1992","journal-title":"Soc. Head. Neck Surg. Comm. Res. Head. Neck"},{"issue":"5","key":"10.1016\/j.prp.2025.156139_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/COC.0b013e31827e4e7b","article-title":"Angiosarcoma outcomes and prognostic factors: a 25-year single institution experience","volume":"37","author":"Buehler","year":"2014","journal-title":"Am. J. Clin. Oncol."},{"issue":"1075","key":"10.1016\/j.prp.2025.156139_bib3","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170039","article-title":"Angiosarcoma: clinical and imaging features from head to toe","volume":"90","author":"Gaballah","year":"2017","journal-title":"Br. J. Radio."},{"issue":"10","key":"10.1016\/j.prp.2025.156139_bib4","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1470-2045(10)70023-1","article-title":"Angiosarcoma","volume":"11","author":"Young","year":"2010","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.prp.2025.156139_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamadermatol.2022.5446","article-title":"Cutaneous angiosarcoma","volume":"159","author":"Klein","year":"2023","journal-title":"JAMA Dermatol."},{"issue":"2","key":"10.1016\/j.prp.2025.156139_bib6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1536\/ihj.20-581","article-title":"Primary cardiac angiosarcoma","volume":"62","author":"Guo","year":"2021","journal-title":"Int Heart J."},{"issue":"5","key":"10.1016\/j.prp.2025.156139_bib7","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cvsm.2019.04.009","article-title":"Histiocytic sarcoma and hemangiosarcoma update","volume":"49","author":"Mullin","year":"2019","journal-title":"Vet. Clin. North Am. Small Anim. Pr."},{"issue":"2","key":"10.1016\/j.prp.2025.156139_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11934-018-0755-6","article-title":"Clinical and pathologic features of primary angiosarcoma of the kidney","volume":"19","author":"Omiyale","year":"2018","journal-title":"Curr. Urol. Rep."},{"issue":"9","key":"10.1016\/j.prp.2025.156139_bib9","article-title":"Hepatic angiosarcoma: a challenging diagnosis","volume":"10","author":"Averbukh","year":"2018","journal-title":"Cureus"},{"issue":"18","key":"10.1016\/j.prp.2025.156139_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037932","article-title":"Etiology, pathogenesis, and management of angiosarcoma associated with implants and foreign body: clinical cases and research updates","volume":"103","author":"Samargandi","year":"2024","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.prp.2025.156139_bib11","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1089\/lrb.2018.0049","article-title":"Cancer risk in klippel-trenaunay syndrome","volume":"17","author":"Blatt","year":"2019","journal-title":"Lymphat Res Biol."},{"issue":"2","key":"10.1016\/j.prp.2025.156139_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41591-019-0749-z","article-title":"The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research","volume":"26","author":"Painter","year":"2020","journal-title":"Nat. Med"},{"issue":"18","key":"10.1016\/j.prp.2025.156139_bib13","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1002\/cncr.24462","article-title":"Secondary sarcomas after radiotherapy for breast cancer: sustained risk and poor survival","volume":"115","author":"Mery","year":"2009","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.prp.2025.156139_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194816","article-title":"Genomic landscape of angiosarcoma: a targeted and immunotherapy biomarker analysis","volume":"13","author":"Espejo-Freire","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.prp.2025.156139_bib15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/hed.24554","article-title":"Predisposing factors for poor prognosis of angiosarcoma of the scalp and face: systematic review and meta-analysis","volume":"39","author":"Shin","year":"2017","journal-title":"Head. Neck"},{"issue":"4","key":"10.1016\/j.prp.2025.156139_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2018.07.010","article-title":"The importance of surgery in scalp angiosarcomas","volume":"27","author":"Cassidy","year":"2018","journal-title":"Surg. Oncol."},{"issue":"11","key":"10.1016\/j.prp.2025.156139_bib17","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2400::AID-CNCR32>3.0.CO;2-Z","article-title":"Angiosarcoma. A report of 67 patients and a review of the literature","volume":"77","author":"Mark","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2025.156139_bib18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijscr.2019.06.006","article-title":"A new case of radiation-induced breast angiosarcoma","volume":"60","author":"Verdura","year":"2019","journal-title":"Int J. Surg. Case Rep."},{"issue":"11","key":"10.1016\/j.prp.2025.156139_bib19","first-page":"2303","article-title":"Angiosarcoma: a review of diagnosis and current treatment","volume":"9","author":"Cao","year":"2019","journal-title":"Am. J. Cancer Res"},{"issue":"4","key":"10.1016\/j.prp.2025.156139_bib20","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/SLA.0000000000001753","article-title":"Cutaneous radiation-associated breast angiosarcoma: radicality of surgery impacts survival","volume":"265","author":"Li","year":"2017","journal-title":"Ann. Surg."},{"key":"10.1016\/j.prp.2025.156139_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fonc.2018.00046","article-title":"Cutaneous angiosarcoma: the possibility of new treatment options especially for patients with large primary tumor","volume":"8","author":"Fujisawa","year":"2018","journal-title":"Front Oncol."},{"issue":"2","key":"10.1016\/j.prp.2025.156139_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/CCO.0000000000000427","article-title":"Cutaneous angiosarcoma: update on biology and latest treatment","volume":"30","author":"Ishida","year":"2018","journal-title":"Curr. Opin. Oncol."},{"issue":"18","key":"10.1016\/j.prp.2025.156139_bib23","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1002\/cncr.34370","article-title":"Clinical activity of checkpoint inhibitors in angiosarcoma: a retrospective cohort study","volume":"128","author":"Ravi","year":"2022","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.prp.2025.156139_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40425-017-0263-0","article-title":"Angiosarcoma treated successfully with anti-PD-1 therapy - a case report","volume":"5","author":"Sindhu","year":"2017","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2025.156139_bib25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12254-017-0365-x","article-title":"Anti-angiogenic therapies for the treatment of angiosarcoma: a clinical update","volume":"10","author":"Young","year":"2017","journal-title":"Memo"},{"issue":"4","key":"10.1016\/j.prp.2025.156139_bib26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/CCO.0b013e32833aaad4","article-title":"Inhibiting the VEGF-VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma\/solitary fibrous tumor","volume":"22","author":"Park","year":"2010","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.prp.2025.156139_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1090168","article-title":"Cutaneous angiosarcoma: a review of current evidence for treatment with checkpoint inhibitors","volume":"10","author":"Guan","year":"2023","journal-title":"Front. Med."},{"issue":"8","key":"10.1016\/j.prp.2025.156139_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002990","article-title":"Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)","volume":"9","author":"Wagner","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.prp.2025.156139_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114188","article-title":"The challenge of running trials in advanced angiosarcoma: a systematic review of the literature from EORTC\/STBSG to guide the development of angiosarcoma-specific trials","volume":"207","author":"Dufresne","year":"2024","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2025.156139_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s13193-023-01814-9","article-title":"Primary angiosarcoma of breast: a case series of rare disease","volume":"15","author":"Sebastian","year":"2024","journal-title":"Indian J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2025.156139_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24413","article-title":"Angiosarcoma of the breast: a review","volume":"10","author":"An","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.prp.2025.156139_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114188","article-title":"The challenge of running trials in advanced angiosarcoma: a systematic review of the literature from EORTC\/STBSG to guide the development of angiosarcoma-specific trials","volume":"207","author":"Dufresne","year":"2024","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.prp.2025.156139_bib33","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/SLA.0b013e3181dbb75a","article-title":"Angiosarcoma: clinical and molecular insights","volume":"251","author":"Lahat","year":"2010","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1016\/j.prp.2025.156139_bib34","first-page":"5370","article-title":"Clinicopathological features and prognostic factors in angiosarcoma: a retrospective analysis of 200 patients from a single Chinese medical institute","volume":"14","author":"Wang","year":"2017","journal-title":"Oncol. Lett."},{"issue":"11","key":"10.1016\/j.prp.2025.156139_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111780","article-title":"Prognostic factors in a large nationwide cohort of histologically confirmed primary and secondary angiosarcomas","volume":"11","author":"Weidema","year":"2019","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.prp.2025.156139_bib36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jgo.2014.02.004","article-title":"Angiosarcoma of the face and scalp: effective systemic treatment in the older patient","volume":"5","author":"Letsa","year":"2014","journal-title":"J. Geriatr. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2025.156139_bib37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00130404-200505000-00011","article-title":"A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy","volume":"11","author":"Fury","year":"2005","journal-title":"Cancer J."},{"issue":"3","key":"10.1016\/j.prp.2025.156139_bib38","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000354215","article-title":"Cutaneous versus non-cutaneous angiosarcoma: clinicopathologic features and treatment outcomes in 60 patients at a single Asian cancer centre","volume":"85","author":"Farid","year":"2013","journal-title":"Oncology"},{"issue":"6","key":"10.1016\/j.prp.2025.156139_bib39","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00432-024-05835-x","article-title":"Angiosarcoma: clinical outcomes and prognostic factors, a single-center analysis","volume":"150","author":"Roohani","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2025.156139_bib40","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00432-024-05835-x","article-title":"Angiosarcoma: clinical outcomes and prognostic factors, a single-center analysis","volume":"150","author":"Roohani","year":"2024","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2025.156139_bib41","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/JTO.0b013e3182106f5c","article-title":"Improved survival after pulmonary metastasectomy for soft tissue sarcoma","volume":"6","author":"Predina","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"12","key":"10.1016\/j.prp.2025.156139_bib42","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/annonc\/mdm381","article-title":"Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases","volume":"18","author":"Fayette","year":"2007","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2025.156139_bib43","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00000478-199806000-00005","article-title":"Angiosarcoma of soft tissue: a study of 80 cases","volume":"22","author":"Meis-Kindblom","year":"1998","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2025.156139_bib44","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s10549-011-1931-2","article-title":"Primary and secondary angiosarcomas of the breast: a single institution experience","volume":"132","author":"Fraga-Guedes","year":"2012","journal-title":"Breast Cancer Res Treat."},{"issue":"32","key":"10.1016\/j.prp.2025.156139_bib45","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1200\/JCO.2008.17.3146","article-title":"Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study","volume":"26","author":"Penel","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2025.156139_bib46","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12105-018-0978-3","article-title":"Characteristics and prognosis of primary head and neck angiosarcomas: a surveillance, epidemiology, and end results program (SEER) analysis of 1250 cases","volume":"13","author":"Lee","year":"2019","journal-title":"Head. Neck Pathol."},{"issue":"11","key":"10.1016\/j.prp.2025.156139_bib47","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up(\u2606)","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2025.156139_bib48","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hed.21513","article-title":"Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp","volume":"33","author":"Guadagnolo","year":"2011","journal-title":"Head. Neck"},{"key":"10.1016\/j.prp.2025.156139_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.113974","article-title":"Propranolol monotherapy in angiosarcoma - a window-of-opportunity study (PropAngio)","volume":"202","author":"Embaby","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.prp.2025.156139_bib50","unstructured":"ClinicalTrials.gov. Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients (PROPANE). 2021."},{"key":"10.1016\/j.prp.2025.156139_bib51","unstructured":"ClinicalTrials.gov. Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma. 2019."},{"issue":"5","key":"10.1016\/j.prp.2025.156139_bib52","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1001\/jamaoncol.2021.3547","article-title":"Efficacy and safety of TRC105 plus pazopanib vs pazopanib alone for treatment of patients with advanced angiosarcoma: a randomized clinical trial","volume":"8","author":"Jones","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.prp.2025.156139_bib53","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejca.2021.06.027","article-title":"An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma","volume":"154","author":"Agulnik","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2025.156139_bib54","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mds237","article-title":"An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas","volume":"24","author":"Agulnik","year":"2013","journal-title":"Ann. Oncol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825003322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825003322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T14:25:49Z","timestamp":1755095149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825003322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":54,"alternative-id":["S0344033825003322"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156139","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological features and prognostic insights of cutaneous versus non-cutaneous angiosarcoma: A retrospective single-center cohort study","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"156139"}}